Evidence map›Paper›PMID 30914436›Full record

ArticleJournal of the American Society of Nephrology : JASN2019

Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice.

Kenichi Ishizawa, Qin Wang, Jinping Li, Ning Xu, Yoshikazu Nemoto, Chikayuki Morimoto, Wataru Fujii, Yoshifuru Tamura, Yoshihide Fujigaki, Kazuhisa Tsukamoto and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Diet-induced obesity impairs salt-dependent downregulation of NCC activity.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Piezo1 dictates KProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Another evidence that supports the continued use of RAS inhibitors in end-stage kidney diseases.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Thermoreceptor TRPV1 regulates body weight and blood pressure in the absence of thermogenin.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  14. NCC regulation by WNK signal cascade.Frontiers in physiology · 2022
    Review
  15. Article
  16. The WNK signaling pathway and salt-sensitive hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
  17. Review
  18. Review
  19. Cullin-Ring ubiquitin ligases in kidney health and disease.Current opinion in nephrology and hypertension · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kenichi IshizawaDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Qin WangDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Jinping LiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Ning XuDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Yoshikazu NemotoDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Chikayuki MorimotoDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Wataru FujiiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Yoshifuru TamuraDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Yoshihide FujigakiDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Kazuhisa TsukamotoDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Toshiro FujitaDivision of Clinical Epigenetics, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-9141-7060
Shunya UchidaDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Shigeru ShibataDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan; shigeru.shibata@med.teikyo-u.ac.jp.ORCID 0000-0002-6868-0626
Teikyo University · JPThe University of Tokyo · JPHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMechanisms underlying the frequent association between salt-sensitive hypertension and type 2 diabetes remain obscure. We previously found that protein kinase C (PKC) activation phosphorylates Kelch-like 3 (KLHL3), an E3 ubiquitin ligase component, at serine 433. We investigated whether impaired KLHL3 activity results in increased renal salt reabsorption

methodsWe used the db/db diabetes mouse model to explore KLHL3's role in renal salt handling in type 2 diabetes and evaluated mechanisms of KLHL3 dysregulation in cultured cells.

resultsWe observed PKC activity in the db/db mouse kidney and phosphorylation of serine 433 in KLHL3 (KLHL3

conclusionsDysregulation of KLHL3 is involved in the pathophysiology of type 2 diabetes. These data offer a rationale for use of thiazide in individuals with diabetes and provide insights into the mechanism for cardiorenal protective effects of SGLT2 inhibitors.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCells, CulturedDiabetes Mellitus, ExperimentalGlucosidesHumansHypertensionKidney Tubules, DistalMiceMice, ObeseMicrofilament ProteinsPhosphorylationProtein Kinase CSensitivity and SpecificitySignal TransductionAdaptor Proteins, Signal TransducingCarrier ProteinsGlucosidesipragliflozinKLHL3 protein, mouseMicrofilament ProteinsProtein Kinase CSodium-Glucose Transporter 2 InhibitorsSolute Carrier Family 12, Member 3ThiophenesWNK Lysine-Deficient Protein Kinase 1Cell Signalingdiabetes mellitusdistal tubulehyperglycemiaNa transport

Identifiers

PMID30914436
PMCPMC6493993
OpenAlexW2923523200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.